ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 108 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $100,000 | +42.9% | 6,276 | +42.4% | 0.00% | +50.0% |
| Q1 2022 | $70,000 | -20.5% | 4,408 | +9.7% | 0.00% | -33.3% |
| Q4 2021 | $88,000 | -55.6% | 4,017 | -39.4% | 0.00% | -50.0% |
| Q3 2021 | $198,000 | +760.9% | 6,630 | +492.0% | 0.01% | +100.0% |
| Q2 2020 | $23,000 | +21.1% | 1,120 | +32.2% | 0.00% | -25.0% |
| Q4 2019 | $19,000 | – | 847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |